Evidence map›Paper›PMID 40023297›Full record

ArticleFree radical biology & medicine2025

Cyclophilin D (CypD) ablation prevents neurodegeneration and cognitive damage induced by caspase-3 cleaved tau.

Margrethe A Olesen, Francisca Villavicencio-Tejo, Gail V W Johnson, George A Porter, Rodrigo A Quintanilla

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Margrethe A OlesenLaboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile.
Francisca Villavicencio-TejoLaboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile.
Gail V W JohnsonDepartment of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, New York, USA.
George A PorterDepartment of Pediatrics, University of Rochester Medical Center, New York, USA.
Rodrigo A QuintanillaLaboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile. Electronic address: rodrigo.quintanilla@uautonoma.cl.

Funding

BAG3 regulates Rab35 and the ESCRT/endolysosome pathwayR01AG073121 · NIA · UNIVERSITY OF ROCHESTER · PI JOHNSON, GAIL V. W. · 2021 to 2025
$2.2M
Cyclophilin D Regulates Neonatal Cardiac Bioenergetics and FunctionR01HL144776 · NHLBI · UNIVERSITY OF ROCHESTER · PI PORTER, GEORGE A · 2019 to 2022
$2.0M
NHLBI NIH HHS R01 HL144776NIA NIH HHS R01 AG073121
6 · The paper itself

Abstract

Abnormal tau modifications are one of the main contributors to neurodegenerative processes present during Alzheimer's disease (AD). In this context, truncated tau by caspase-3, a pathological tau form, affects mitochondrial function and antioxidant regulation, contributing to synaptic and cognitive impairment in AD mouse models. We previously showed that the presence of caspase-3 cleaved tau promotes mitochondrial impairment in neuronal cells, where Cyclophilin-D (CypD) protein could be a crucial element. CypD is considered the master regulator of mitochondrial permeability transition pore (mPTP) opening, and its ablation prevents neurodegenerative and cognitive damage induced by β-amyloid in mouse models of AD. However, the possible role of CypD in the neurodegenerative processes mediated by caspase-3-cleaved tau has not been explored. Here, we use tau (-/-) and CypD (-/-) knock-out mice that were subjected to right-side hippocampal stereotaxic injection to induce GFP (AAV-Syn-GFP), full-length (AAV-Syn-GFP-T4) or caspase-3-cleaved (AAV-Syn-GFP-T4C3) tau expression. Then, cognitive performance, synaptic architecture, and hippocampal mitochondrial function were evaluated two months later. We observed that caspase-3 cleaved tau expression inducing cognitive decline, vesicle and synaptic protein deregulation, and mitochondrial impairment generated by the mPTP opening. More interestingly, when caspase-3 cleaved tau was expressed in the hippocampus of CypD (-/-) mice, cognitive decline, synaptic impairment, and mitochondrial damage mediated by mPTP were prevented, demonstrating a novel role of CypD in neurodegenerative changes induced by truncated tau in AD.

Indexed as

Alzheimer DiseaseCaspase 3Cognitive DysfunctionCyclophilinstau ProteinsAnimalsDisease Models, AnimalHippocampusHumansMaleMiceMice, KnockoutMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreNeuronsCaspase 3CyclophilinsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePeptidyl-Prolyl Isomerase FPPIF protein, mousetau ProteinsAlzheimer diseaseCaspase-3 cleaved tauCognitive impairmentCyclophilin-D (CypD)Mitochondrial dysfunctionmPTP

Identifiers

PMID40023297
PMCPMC11985267

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.